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Nuclear reprogramming requires the removal of epigenetic mod-
ifications imposed on the chromatin during cellular differentiation
and division. The mammalian oocyte can reverse these alterations
to a state of totipotency, allowing the production of viable cloned
offspring from somatic cell nuclei. To determine whether nuclear
reprogramming is complete in cloned animals, we assessed the
telomerase activity and telomere length status in cloned embryos,
fetuses, and newborn offspring derived from somatic cell nuclear
transfer. In this report, we show that telomerase activity was
significantly (P < 0.05) diminished in bovine fibroblast donor cells
compared with embryonic stem-like cells, and surprisingly was
16-fold higher in fetal fibroblasts compared with adult fibroblasts
(P < 0.05). Cell passaging and culture periods under serum star-
vation conditions significantly decreased telomerase activity by
approximately 30–50% compared with nontreated early passage
cells (P < 0.05). Telomere shortening was observed during in vitro
culture of bovine fetal fibroblasts and in very late passages of
embryonic stem-like cells. Reprogramming of telomerase activity
was apparent by the blastocyst stage of postcloning embryonic
development, and telomere lengths were longer (15–23 kb) in
cloned fetuses and offspring than the relatively short mean ter-
minal restriction fragment lengths (14–18 kb) observed in adult
donor cells. Overall, telomere lengths of cloned fetuses and new-
born calves (’20 kb) were not significantly different from those of
age-matched control animals (P > 0.05). These results demonstrate
that cloned embryos inherit genomic modifications acquired dur-
ing the donor nuclei’s in vivo and in vitro period but are subse-
quently reversed during development of the cloned animal.
The production of viable, fertile cloned animals by nucleartransplantation of somatic cells from cultured cell lines and
adult tissues (1, 2) has challenged our understanding of terminal
cell differentiation, cellular aging, and the proliferative capacity
of cells. Successful cloning requires the reprogramming of the
donor nuclei from pluripotent or differentiated cells to an
undifferentiated state to permit the temporal and spatial reex-
pression of genes involved in embryo and fetal development.
Somatic nuclei progressively acquire differentiated functions
through the gradual implementation of epigenetic chromatin
modifications during embryogenesis and postembryonic devel-
opment (3). Amazingly, the cytoplasm of the mammalian oocyte
can, under optimal conditions, reverse the changes to the
chromatin structure and function of the differentiated trans-
planted nucleus to a state of totipotency. The inefficiency in the
nuclear reprogramming has been suggested as one of the major
causes of the high rate of embryonic, fetal, and neonatal failures
observed after nuclear transplantation (4).
One characteristic structural DNA change of most dividing in
vivo and in vitro somatic cells is the shortening of the telomeres,
the long tandem arrays of hexameric DNA sequences
(TTAGGG)n at the ends of mammalian chromosomes, during
DNA replication (5–7). Telomeres are critical structures that
function in the stability, replication, and segregation of the
chromosome during mitosis (8), and the gradual loss of telomeric
sequence has been proposed as a ‘‘mitotic clock’’ leading to cell
cycle arrest or cellular senescence (9). Conventional DNA
polymerases cannot replicate the extreme 59 ends of chromo-
somes because removal of the most terminal RNA primer in the
lagging strand leaves a small region of uncopied DNA (10). This
telomeric DNA loss has been calculated to be between 50 and
200 bp per cell division (11, 12). Once telomeres shorten below
a critical length, they lose the capacity to cap chromosomes
effectively and are thought to activate a DNA damage response
pathway that causes cell cycle arrest (13).
Cells can overcome this ‘‘end-replication problem’’ by the
activationyexpression of the ribonucleoprotein telomerase,
which synthesizes TTAGGG repeats de novo onto the ends of
chromosomes (14). This multisubunit, reverse transcriptase, uses
its RNA component as a template for the synthesis of telomeric
DNA. Normal human somatic cells do not express telomerase
activity and therefore have a limited replicative life span in vitro
(15). Telomerase activity and maintenance of telomere length
has been observed in the germ line and in most immortal cell
lines and tumor samples analyzed thus far (16, 17). The intro-
duction of the telomerase catalytic subunit (hTERT) into nor-
mal human diploid cells displayed normal growth controls and
normal karyotypes and succeeded in extending the life span of
the cells (18, 19). Late-generation mice lacking the telomerase
RNA (mTR2/2) component displayed shortened telomeres and
chromosome abnormalities and exhibited defective spermato-
genesis, increased apoptosis, and decreased proliferation in the
testis, bone marrow, and spleen (20). Thus, telomerase activity
in the germ line is thought to prevent cumulative telomere
shortening from generation to generation.
The telomere hypothesis of aging can be tested in vivo by the
use of nuclear transfer technology because it allows the produc-
tion of cloned animals from adult and cultured somatic cells,
without the involvement of the germ line. Sheep cloned by
nuclear transfer of cultured cells from embryonic or fetal tissue
showed telomere shortening of approximately 10–15% com-
pared with age-matched controls (21, 22). Furthermore, Dolly,
cloned from a cultured mammary cell from a 6-year-old ewe,
displayed telomere loss of approximately 20% (21, 22). There-
fore, both the age of the donor nucleus and the proliferation in
culture contributed to the telomeric loss observed in this small
sample size of cloned sheep. In contrast, Lanza et al. (23) have
demonstrated the reversal of cellular aging with the use of
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senescent donor somatic cells as the nuclear donor. Fibroblasts
from bovine fetuses cloned from these cells displayed an ex-
tended replicative life span and rebuilding of telomere length
compared with control fetal fibroblasts (FFs) and senescent
fibroblasts, respectively (23). Moreover, nucleated blood cells
from 5- to 10-month-old cloned cattle appeared to have longer
telomere lengths compared with newborn and age-matched
control animals (23).
The aims of this study were as follows: (i) to determine the
effects of in vitro culture and serum deprivation on telomerase
activity and telomere length in bovine cell types used for cloning
and (ii) to determine whether telomerase activity is repro-
grammed and telomere length is restored after nuclear transfer
(cloning) of cultured somatic cells. To accomplish these goals we
have compared telomerase activity and telomere lengths in
early- and late-passage bovine fibroblasts and embryonic stem
(ES)-like cells, cloned embryos reconstructed with the use of
various donor cell types, cloned fetuses, and live-born offspring
with their original donor cell cultures and age-matched controls.
Here we report that although telomere length and telomerase
activity decline in bovine cells during in vitro culture, telomerase
activity is reprogrammed as early as the blastocyst stage, and the
telomere length is rebuilt in cloned cattle reconstructed with the
use of donor nuclei from cultured adult and fetal cells.
Materials and Methods
Cells and Primary Tissues. Bovine fetal tissues and fibroblasts were
prepared either from 40- to 50-day-old fetuses or from cloned
fetuses surgically removed from the recipients’ uteri. Tissues
were minced, and either they were snap frozen (280°C) for later
analysis or the cells were isolated by multiple trypsinyEDTA
treatments (0.25% trypsiny0.02% EDTA; GIBCOyBRL) for 10
min at 37°C. Cells were washed and plated in tissue culture flasks
with DMEM (GIBCOyBRL) 1 10% FCS and 0.5% antibiotics
(10,000 units of penicillin per ml and 10,000 mg of streptomycin
per ml; GIBCOyBRL). The calf and adult bovine fibroblast cell
lines were derived from surgical excisional biopsies. Thin (1–3
mm) pieces of the s.c. tissue were transferred into 25 mm2 flasks
containing DMEM 1 10% FBS 1 1% (volyvol) penicilliny
streptomycin and cultured at 37°C in air containing 5% CO2.
To establish ES-like cell lines, the inner cell mass of bovine
blastocysts was mechanically isolated and placed onto mitomycin
C (Sigma; 10 mgyml, 3 h)-arrested mouse fibroblasts plated onto
0.1% gelatin (Sigma)-coated 60-mm Petri dishes (Nunc). The
cells were cultured in DMEM supplemented with 20% charcoal-
treated FCS, nucleosides (Sigma; 0.03 mM adenosine, 0.03 mM
cytidine, 0.03 mM guanosine, 0.03 mM uridine, and 0.01 mM
thymidine), nonessential amino acids (Sigma), 2 mM L-
glutamine (Sigma), 0.1 mM 2-mercaptoethanol (Sigma), and
antibiotics. Culture medium was replaced every 3 days, and
growing cells were mechanically replated every 7–12 days. Cells
were individualized by treatment with 0.3% protease E (Sigma)
in PBS. Both ES-like cells and fibroblasts were either serum
starved (0.5% FCS 1 DMEM, 1–10 days) or serum fed (10%
FCS 1 DMEM) before nuclear transfer or analysis.
Granulosa cells were recovered by transvaginal follicular
aspiration from a 5-year-old Holstein. Cells were separated by
shaking in PBS, washed in DMEM with 10% FCS 1 antibiotics,
and plated in tissue culture flasks with the same medium.
TrypsinyEDTA treatment was used for cell passaging once every
7 days and to obtain donor cells for oocyte reconstruction.
In Vitro Bovine Oocyte and Embryo Culture. Cumulus–oocyte com-
plexes were aspirated from follicles 2–10 mm in diameter, and in
vitro oocyte and embryo culture methods (24) were used for the
production of in vitro fertilized and cloned bovine preattachment
embryos. Embryos were cocultured in either TCM-199
(GIBCOyBRL) or Menezo’s B2 medium (Pharmascience, Paris,
France) supplemented with 10% FCS in the presence of bovine
oviduct epithelial cells or BRL cells in a humidified atmosphere
of 5% CO2 in air at 39°C.
Oocyte Reconstruction by Nuclear Transfer. The methods for oocyte
enucleation, somatic cell–oocyte fusion, embryo activation,
cloned embryo culture, and embryo transfer into synchronized
recipients were carried out as described (25, 26). Bovine oocytes
were reconstructed by nuclear transfer with the use of bovine
adult fibroblasts, FFs, or granulosa cells as the nuclear donor.
Measurement of Telomerase Activity and Telomere Length. Telom-
erase activity was measured by telomere repeat amplification
protocol (TRAP) with the TRAPEZE telomerase detection kit
(Intergen Company, Purchase, NY) as described (24). Cultured
bovine cells, embryos, and tissues were extracted in Nonidet P-40
lysis buffer [10 mM Tris (pH 7.5)y1 mM MgCl2y1 mM EGTAy
150 mM NaCly10% glyceroly0.1 M PMSFy0.01% 2-mercapto-
ethanoly0.12 M sodium deoxycholatey1% Nonidet P-40] and
100 unitsyml RNase inhibitor (Roche Molecular Biochemicals).
To compare relative telomerase activities in the linear range the
optimal embryo equivalents or protein content used for each
TRAP assay was determined by serial dilutions of each cell
extract. The extended TRAP products were amplified by PCR,
resolved on 12% polyacrylamide gels, and revealed by exposure
to a PhosphorImager cassette (MOLECULAR ANALYST Software;
Bio-Rad). The relative telomerase activity was determined for
each sample by the densitometric analysis of TRAP reaction
products in relation to its 36-bp internal standard and the TRAP
signals for the positive cell extract (immortalized 293 cells) and
its 36-bp internal standard.
Mean telomere length was determined by terminal restriction
fragment (TRF) analysis with the TeloQuant Telomere Length
Assay Kit (PharMingen). Isolated DNA (2.5–10 mg) was digested
with a HinfIyRsaI enzyme mixture (4 unitsymg of DNA;
GIBCOyBRL and Life Technologies, Grand Island, NY) for
12–16 h at 37°C. Undigested and digested DNA samples were
resolved by 0.6% agarose gel electrophoresis at 5 Vycm for 2–3
h to check the integrity and complete digestion of genomic DNA,
respectively. Digested DNA samples were then resolved by 0.6%
agarose gel electrophoresis at 1 Vycm overnight (24 h). Gels
were denatured, neutralized, and Southern transferred to a
positively charged nylon membrane (Amersham Hybond-N1),
which was then hybridized with a biotinylated telomere probe
(TeloQuant; PharMingen). Mean TRF lengths were analyzed
from a densitometric scan of the autoradiogram and calculated
as described (11). Experiments were repeated a minimum of
three times on different cell, embryo, and tissue samples.
Statistical analyses were performed with the use of a post hoc test
(Tukey–Kramer) for multiple comparisons to determine the
significance of the differences (P , 0.05) between mean relative
telomerase activities and mean TRF lengths (27).
Results
Telomerase Activity in Bovine Cell Lines. Telomerase activity in
bovine cell lines displayed a profile similar to that of the same
cell types of other species (7, 28, 29). Bovine ES-like cells
exhibited a considerably higher level of telomerase activity in
relation to fibroblast cells (P , 0.05), the levels of which were
barely detectable (Fig. 1 C and D). Similarly, bovine FFs (first
passage) displayed a significantly (P , 0.05) higher relative
telomerase activity compared with adult fibroblasts (fourth
passage). Although telomerase processivity was low, telomerase
activity was almost 16 times greater in FFs compared with the
adult cells (Fig. 1 A and B). The relatively low levels of
telomerase activity observed in bovine fibroblasts are probably
due to the lack of active telomerase enzyme rather than the
presence of telomerase inhibitors because mixing experiments of
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ES extracts with fibroblast extracts did not significantly (P .
0.05) diminish TRAP products compared with controls (data
not shown).
The Effect of Cell Passage and Serum Starvation on Telomerase
Activity. Serum starvation of cultured somatic cells before nu-
clear transfer is used to increase the percentage of cells in the
G0yG1 cell cycle stage and is thought to improve the pregnancy
rates of cloned embryos (30). To assess the impact of cell passage
number and serum starvation, telomerase was determined in two
bovine cell lines used in nuclear transfer protocols. The telom-
erase activity of both the bovine ES-like cells (Fig. 1E) and
bovine FFs (Fig. 1F) significantly decreased from early to late
cell passage (P , 0.05). Telomerase activity decreased by 31%
and 42% from early to late cell passage in ES-like cells (34th
passage) and FFs (24th passage), respectively. Similarly, telom-
erase activity levels of early passage stem cells (eighth passage)
and fibroblasts (first passage) significantly decreased by days 5
and 10 of serum starvation conditions (P , 0.05). By 10 days of
serum starvation telomerase levels decreased by 44.8% and
51.4% in ES-like cells (Fig. 1E) and FFs (Fig. 1F), respectively,
compared with early-passage nontreated cells.
Telomere Length of Early- and Late-Passage Bovine FFs and ES-Like
Cells. To examine the effect of in vitro cell division on telomere
length, the mean TRF length was determined for early- and
late-passage bovine FFs and ES-like cells. Mean TRF lengths
were determined from two independent samples for each cell
line and analyzed twice in separate experiments. The mean TRF
length decreased with passage number in FFs (Fig. 2A) and,
surprisingly, in telomerase-positive bovine ES-like cells (Fig. 2 B
and C). The mean TRF length shortened from 21.17 kb at early
passages (population doubling, PD 5 4) to 16.45 kb at late PDs
(PD 5 33) in bovine FFs (Fig. 2 A). Analysis of multiple
fibroblast samples from different cell passages revealed that the
telomeres shortened at a rate of approximately 163 bases with
each PD. Telomere length was maintained at around 19 kb from
early passage (fourth passage) to late passages (37th passage) in
ES-like cell cultures (Fig. 2B). However, after many subcultures
(52 passages; approximately 600–650 PDs) ES-like cells dis-
played extremely short TRF lengths of approximately 3.28 kb
(Fig. 2C).
Nuclear Reprogramming of Telomerase Activity. The TRAP assay
was used to ascertain whether reprogramming of telomerase
expression occurred in cloned embryos. Initial experiments
detected the presence of telomerase activity in tissues from a
40-day cloned fetus reconstructed with the use of an adult
fibroblast cell line from a 21-year-old bull (Fig. 3A). Protein
extracts from kidney and liver samples from the cloned fetus
were positive for telomerase activity, which is normally detected
in these tissues during fetal gestation (Fig. 3A). Cloned bovine
blastocysts, reconstructed with the use of bovine FFs and
granulosa cells, exhibited telomerase activity like that of their in
vitro-fertilized counterparts (Fig. 3 B and D). A more detailed
analysis revealed that high levels of telomerase activity were not
detected before the blastocyst stage of cloned embryo develop-
ment (Fig. 3C).
Analysis of Telomere Length in Cloned Cattle. We sought to deter-
mine, with the use of TRF analysis, whether the telomere lengths
of cloned fetuses and offspring reflect those of progenitor donor
nuclei or age-matched control fetuses and animals. Chemilumi-
nescent detection of telomeric DNA in cloned fetal and calf
animals revealed that telomere lengths were longer than those
measured for their donor cells (Fig. 4). Mean TRF lengths
increased from 13.68 kb in progenitor adult fibroblasts from a
9-year-old Charolais female to 17.95 kb and 15.32 kb in cloned
Fig. 1. The effect of cell passage number and serum starvation on telomerase
activity. Telomerase activity was measured in protein extracts (0.5 mg) from
adult fibroblast (AF) (passage 4) and FF (passage 1) cell lines (A) and in protein
extracts (0.25 mg) from bovine ES-like cells (passage 8) and FF (passage 1) cell
lines (C), with the use of the TRAP assay. Heat-inactivated (HI) control, positive
293 cell extract control (1), and negative lysis buffer control (2), are displayed.
(B–F) Densitometric analyses of TRAP reaction products displaying the relative
telomerase activities between bovine cell samples. Telomerase activity was
measured in protein extracts (0.25 mg) from (E) bovine ES cell-like cells and (F)
FFs at early passage (EP) (passages 8 and 1, respectively) and late passage (LP)
(passages 34 and 24, respectively) and early-passage cells after increasing
incubation times under serum starvation (SS) conditions (24 h, 48 h, 5 days, 10
days). Asterisks (*) denote significant differences (P , 0.05) between mean
telomerase activities.
Fig. 2. Chemiluminescent detection of telomere length in bovine cells
during in vitro culture. (A–C) TRF analysis demonstrating telomere length in
early-passage (EP) and late-passage (LP) FFs and bovine ES-like cells cultured
under 5% CO2 in air atmosphere. (A) Telomere length decreased in FF cells
from early (4 PD) to late cell passages (33 PD). (B) Telomere length was
maintained in the early passages (EP 5 passage 4; LP 5 passage 37) of ES-like
cell cultures but (C) shortened in ES cells (derived from same starting clone) at
very late passages (passage 52; approximately 600–650 population dou-
blings). Molecular weight (MW) markers (lane M) are displayed in kilo-
bases (kb).
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FFs and cloned calf fibroblasts, respectively (Fig. 4A). Although
frozen aliquots of adult donor cell samples from a 21-year-old
Brahman bull were destroyed during a freezer malfunction and
the bull had died, and recovered tissue was unsuitable for cell
culture (26), DNA recovery from frozen muscle tissue was
achieved for TRF analysis. Mean TRF lengths were also shown
to increase from 17.85 kb in adult muscle tissue from a 21-year-
old Brahman bull to 22.74 kb and 21.33 kb in cloned fetal liver
tissue and cloned calf fibroblasts, respectively (Fig. 4B). Telo-
mere length analysis of different tissue samples from multiple
cloned calves (,3 weeks old) generated from the same donor cell
line displayed distinct variations in mean TRF lengths between
cloned animals and between different tissues within each clone
as well (Fig. 5). After we compiled and compared the mean TRF
length data on all cloned fetal (n 5 5) and cloned calf samples
(n 5 16) with age-matched and tissue-matched controls (n 5 22),
no significant differences (P . 0.05) in telomere lengths were
observed (Fig. 6). Mean TRF lengths were calculated to be
approximately 20.90 6 0.33 kb and 20.54 6 0.85 kb in control
fetal and newborn animals, respectively, and were 21.45 6 0.97
kb and 19.03 6 0.39 kb in cloned fetuses and newborn calves,
respectively (Fig. 6).
Fig. 3. Reprogramming of telomerase activity in cloned bovine fetuses and
embryos. Telomerase activity was assessed in protein extracts (0.5 mg) of
bovine cell lines and fetuses and in the equivalent of one bovine embryo. (A)
Telomerase activity status of bovine adult fibroblasts (AF) and the cloned fetal
kidney (cFK) and liver (cFL) tissues produced from the reconstruction of adult
fibroblast nuclei with enucleated bovine oocytes. Telomerase activity of fetal
kidney (FK) and liver (FL) tissues from a natural mating is shown as positive
controls. (B) Comparison of telomerase activity between in vitro-fertilized
zygotes (1C) and blastocysts (Blast) with reconstructed embryos (Nuclear
Transfer), with FFs as the donor nuclei. (C) Developmental expression of
telomerase activity within cloned embryos. Telomerase activity was analyzed
in cloned one-cell (1C) and 8- to 16-cell (8–16C) morulae (MR) and blastocysts
(BL) reconstructed with nuclei from bovine FFs. (D) Reprogramming of telom-
erase activity in cloned bovine blastocysts (BL) derived from bovine granulosa
cells (GC). Heat-inactivated (HI), positive cell extract control (1), and negative
lysis buffer control (2) samples were used in each assay.
Fig. 4. Rebuilding of telomere length in cloned cattle. Chemiluminescent
detection of TRF lengths of RsaIyHindfI-digested DNA from cells and tissues of
cloned fetuses and calves compared with their donor cells from a 9-year-old
Charolais female (A) and from a 21-year-old Brahman bull (B). Mean TRF
lengths were measured in DNA samples from adult (A) donor cells and samples
from cloned (NT) fetal (F) and calf (C) animals. Molecular weight (MW) markers
(lane M) are displayed in kb.
Fig. 5. Variation of telomere lengths between cloned calves and among
different tissues within each cloned animal. (A) TRF analysis of digested DNA
from various tissue samples of multiple clone calves (#1–#5; ,3 weeks old)
derived from the same bovine FF cell line. Samples are skin (S), s.c. (SC), testis
(Ts), muscle (Ms), kidney (Kd), and blood (Bl). Molecular weight markers (M)
are in kilobases. (B) Densitometric analysis of TRF profiles revealing mean TRF
lengths of different samples (skin, s.c., and blood) from multiple cloned
offspring (#1, #2, #4, #5). (C) Mean TRF lengths in testis (Ts) (mean TRF length 5
19.63 kb), liver (Lv) (mean TRF length 5 17.76 kb), muscle (Ms) (mean TRF
length 5 19.23 kb), and kidney (Kd) (mean TRF length 5 16.16) tissues from
clone #3.
Fig. 6. Comparison of telomere lengths between cloned cattle and age-
matched controls. Densitometric analysis of TRF lengths generated from
RsaIyHindfI digestion of genomic DNA from cloned (NT) fetuses and newborn
calves compared with age-matched control (CONT) cattle.
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Discussion
The results presented in this study clearly show that telomere loss
occurs in cultured bovine fibroblasts and ES-like cells; however,
cloned cattle, reconstructed from cultured adult and fetal so-
matic cells, display telomere lengths similar to those of age-
matched control animals. The rebuilding of telomeric sequences
from shorter telomere lengths observed in the donor cells could
be due to the presence of telomerase activity, detected as early
as the first week of postcloning embryonic development. Re-
programming of telomerase activity was observed as early as the
blastocyst stage in nuclear transfer bovine embryos that were
reconstructed with the use of various donor nuclei that display
lowynondetectable levels of telomerase. This appearance of
telomerase activity in cloned embryos is delayed compared with
fertilization-derived bovine embryos, in which relatively high
levels of telomerase activity are observed after activation of the
embryonic genome at the 8–16-cell stage (24). Other studies
have examined structural and functional reprogramming events
in reconstructed embryos, including nucleolar and mitochon-
drial morphology (31), nuclear swelling (32), and the exchange
of somatic histone H1 subtypes (25). These studies have dem-
onstrated that nuclear reprogramming takes place over several
cell cycles and may be delayed or incomplete in the transferred
nucleus (32, 33). Recently, a differential display analysis that
compared cDNA profiles between nuclear-transferred bovine
blastocysts with in vivo- and in vitro-derived blastocysts demon-
strated that most but not all of the mRNAs are reprogrammed
in cloned embryos (34). Specific epigenetic DNA modifications
are probably required for proper transcriptional activation of the
embryonic genome. The lack of complete genetic reprogram-
ming of gene expression and chromatin structure may lead to the
developmental failures and abnormalities observed in cloned
embryos, fetuses, and offspring (3, 4).
The telomere loss observed in donor somatic cells has been
attributed to the age of the donor animal and culture propaga-
tion of the cells in vitro (21–23). In this study, telomere attrition
was observed in bovine FFs and surprisingly within telomerase-
positive bovine ES-like cells after many cell passages. Although
the low levels of telomerase activity can account for the shorter
telomeres observed in late passage bovine fibroblasts, the short-
ening of telomere length observed in late-passage ES-like cells
may be due to the observed decline in telomerase activity. Other
reports have demonstrated decreased telomerase expression in
dividing stem cells in culture, with an associated shortening of
telomere lengths (35, 36). These studies suggest that the ob-
served telomerase activity in candidate bovine stem cells is not
sufficient to prevent telomere shortening. Single-stranded telo-
meric DNA damage, caused by oxygen free radicals, has been
shown to accumulate in cells after prolonged periods of culture
and confluency, leading to an increased rate of telomeric
shortening in fibroblasts (37). This oxidative stress-induced
telomeric damage has also been observed in telomerase-positive
cells grown in culture (38). The reduced telomerase activity
levels observed in late-passage bovine ES-like cells may repair
telomeric damage but do not prevent the telomere shortening
produced by the ‘‘end replication problem.’’ Early-passage cells
cultured under serum starvation conditions may also be suscep-
tible to increased telomeric damageyshortening because of
reduced telomerase levels due to cell cycle exit into the quiescent
(Go) state (39).
In our study, telomere rebuilding was observed in multiple
tissue and cell samples from cloned bovine fetuses and newborn
calves derived from cultured fetal and adult cell lines. The mean
TRF lengths of nuclear transfer bovine fetuses and offspring
were not significantly different from those of age-matched
control samples. However, we did find animal-to-animal varia-
tion and tissue-to-tissue variation between and within newborn
cloned calves, respectively. Previous studies have shown signif-
icant telomere length differences among individuals, and the
telomere synchrony observed in fetal tissues is lost during
postnatal life (7, 40). The telomere length variations among and
within newborn calves could be due to donor cell selection,
tissueyanimal-specific differences in telomere rebuilding,
andyor the different proliferative rates of different tissues (40).
Our results and those of Lanza et al. (23) are in contrast to
observations on cloned sheep, which were shown to have short-
ened telomeres (21, 22). Despite having shorter mean TRF
lengths, nuclear-transfer sheep are healthy, fertile, and typical
for sheep of their breeds (21, 22). The birth of cloned offspring
and their development to adulthood strongly suggests that
proliferative capacity of late-passage tissue culture cells (23) and
cells from very old adult animals (1, 26) can be restored to a
considerable degree by nuclear transplantation (41). However, it
has not been determined whether telomere length accurately
reflects the physiological age of an animal. Mice deficient in
telomerase activity only show a disrupted phenotype after 4–5
generations (20, 42), and the sequential cloning of mice by
transfer of adult cumulus cell nuclei shows no adverse effects
(43). It must be noted, however, that mice telomeres are
substantially longer than those of other species, and telomerase
activity is present in most of their adult somatic cells (7).
We did not observe any significantly elongation of telomere
length in any of the cells and tissues examined from cloned cattle
beyond that of control animals, as Lanza et al. (23) recently
reported for nucleated blood cells of cloned calves. The discrep-
ancies in telomere length reported for cloned animals could be
due to differences in donor cell type, nuclear transfer procedure,
and species (23), but also suggest that other regulatory mecha-
nisms other than just the presence of telomerase activity may be
involved in determining telomere length. Each vertebrate spe-
cies has a set characteristic maximum telomere length (7, 44, 45),
and many immortalized and cancer cell lines where telomerase
has been reactivated show extremely high levels of telomerase
activity that only maintains short telomeres (17). Telomere-
specific binding proteins such as telomeric repeat binding fac-
tor-1, telomeric repeat binding factor-2, tankyrase, and telo-
meric repeat binding factor-1 interacting nuclear protein-2 have
recently been implicated as mediators of telomere length (46–
48). These proteins may directly inhibityfacilitate the binding of
telomerase to telomeric DNA or provide structural changes
within the telomere that preventypromote telomerase binding.
Interestingly, telomeric repeat binding factor-2 is up-regulated in
senescent human fibroblasts (49). Complex telomere remodeling
and telomerase regulation during nuclear reprogramming may
promote telomere restoration and possibly telomere length
extension in cloned offspring. Alternatively, because most of the
cloned calves studied by Lanza et al. (23) experienced pulmonary
hypertension, respiratory distress and fever before 4 months of
age, an activated immune response might have triggered an
up-regulation of telomerase activity and subsequent lengthening
of the telomeres in nucleated blood cells, as demonstrated
previously (50).
In summary, we have observed the reprogramming of telom-
erase activity and the restoration of telomere length in cloned
cattle derived from the nuclear transfer of cultured and aged
somatic cells. The telomere rebuilding observed in cloned cattle
may be attributed to the nuclear reprogramming of telomerase
activity that was detected at the blastocyst stage of cloned
embryo development. Detection of telomerase reexpression
could be used as a marker to assess the extent and timing of
nuclear reprogramming in reconstructed embryos. These results
demonstrate that cloned offspring repair genomic modifications
acquired during the donor nuclei’s in vivo and in vitro period
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before nuclear transfer, suggesting that along with telomere
shortening, nuclear reprogramming outside of the germ line may
repair other forms of DNA alterations, such as DNA damage.
Telomere research on cloned mammals may determine the
mechanism and timing of telomere restoration and any physiolog-
ical effects of somatic cell nuclear transfer on the aging process.
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